IQE PLC
31 July 2006
IQE PLC
31 July 2006
IQE plc
(the ''Company'')
DIRECTORS' DEALINGS
IQE plc announces that 104,555 new ordinary shares have been issued in payment
of Non Executive Directors' fees for April/June 2006. Following this issue the
total number of ordinary shares in issue is 317,017,748. The shares will be
allotted and issued in the form of block certificates as detailed below:
Non Exec Director Shares issued Average price
Dr Godfrey Ainsworth 69,703 14.75p
Following this issue Non-executive Chairman of the Company Dr Godfrey
Ainsworth's total shareholding in the company is 2,877,968 shares, representing
0.91% of the current issued share capital. The remaining 34,852 shares were
issued to Wesley Clover Wales Limited in settlement in fees for Non Executive
Director, Simon Gibson, which Simon does not hold a beneficial interest.
Application has been made to the Financial Services Authority for the shares to
be admitted to AIM.
Contacts
IQE plc +44(0) 29 2083 9400
Dr Drew Nelson, President & CEO
Stuart Hall, CFO
Chris Meadows, Investor Relations
Noble & Company Limited +44(0) 20 7763 2200
John Llewellyn-Lloyd
Graeme Bayley
This information is provided by RNS
The company news service from the London Stock Exchange LB
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.